sb 203580 has been researched along with nsc-87877 in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (nsc-87877) | Trials (nsc-87877) | Recent Studies (post-2010) (nsc-87877) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 40 | 0 | 30 |
| Protein | Taxonomy | sb 203580 (IC50) | nsc-87877 (IC50) |
|---|---|---|---|
| Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) | 0.36 | |
| Tyrosine-protein phosphatase non-receptor type 11 | Homo sapiens (human) | 0.319 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbieri, E; Chen, Z; Cheng, J; Fan, Y; Jin, J; Kim, ES; Ma, IT; Patel, RH; Rojas, Y; Shang, X; Shi, Y; Shohet, JM; Vasudevan, SA; Yang, J; Yu, Y; Zhao, Y | 1 |
1 other study(ies) available for sb 203580 and nsc-87877
| Article | Year |
|---|---|
NSC-87877 inhibits DUSP26 function in neuroblastoma resulting in p53-mediated apoptosis.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Caspase 3; Cell Line, Tumor; Dual-Specificity Phosphatases; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Heat-Shock Proteins; HSP27 Heat-Shock Proteins; Humans; Imidazoles; Intracellular Signaling Peptides and Proteins; Kidney; Mice; Mice, Nude; Mitogen-Activated Protein Kinase Phosphatases; Molecular Chaperones; Neuroblastoma; p38 Mitogen-Activated Protein Kinases; Poly(ADP-ribose) Polymerases; Protein Serine-Threonine Kinases; Pyridines; Quinolines; RNA, Small Interfering; Signal Transduction; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2015 |